US researchers eye developing mucosal vaccines for respiratory viruses
Jan 16, 2023, 03:00 PM ISTFlu, RSV, SARS-CoV-2 and "common cold" coronaviruses share several characteristics that enable them to cause repeated re-infections, including very short incubation periods, rapid host-to-host transmission and replication in the nasal mucosa rather than throughout the body.